GERN FY 2022 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$596,000-57.2% YoY

Gross Profit

$596,000100.0% margin

Operating Income

-$139M-23246.6% margin

Net Income

-$142M-23808.9% margin

EPS (Diluted)

$-0.37

Cash Flow

Operating Cash Flow

-$127M

Free Cash Flow

-$128M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$191M

Total Liabilities

$111M

Stockholders' Equity

$80M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$596,000	$1M	-57.2%
Gross Profit	$596,000	$1M	-57.2%
Operating Income	-$139M	-$114M	-21.5%
Net Income	-$142M	-$116M	-22.2%